T. Sakurai, A. Amemiya, M. Ishii, I. Matsuzaki, and R. Chemelli, Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior, Cell, vol.92, issue.4, pp.573-585, 1998.
DOI : 10.1016/S0092-8674(00)80949-6

D. Lecea, L. Kilduff, T. Peyron, C. Gao, X. Foye et al., The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity, Proceedings of the National Academy of Sciences, vol.95, issue.1, pp.322-327, 1998.
DOI : 10.1073/pnas.95.1.322

L. Lin, J. Faraco, R. Li, H. Kadotani, and W. Rogers, The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene, Cell, vol.98, issue.3, pp.365-376, 1999.
DOI : 10.1016/S0092-8674(00)81965-0

R. Chemelli, J. Willie, C. Sinton, J. Elmquist, and T. Scammell, Narcolepsy in orexin Knockout Mice, Cell, vol.98, issue.4, pp.437-451, 1999.
DOI : 10.1016/S0092-8674(00)81973-X

T. Thannickal, R. Moore, R. Nienhuis, L. Ramanathan, and S. Gulyani, Reduced Number of Hypocretin Neurons in Human Narcolepsy, Neuron, vol.27, issue.3, pp.469-474, 2000.
DOI : 10.1016/S0896-6273(00)00058-1

C. Peyron, J. Faraco, R. W. Ripley, B. Overeem, and S. , A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains, Nat Med, vol.6, pp.991-997, 2000.

B. Ripley, S. Overeem, N. Fujiki, S. Nevsimalova, and M. Uchino, CSF hypocretin/orexin levels in narcolepsy and other neurological conditions, Neurology, vol.57, issue.12, pp.2253-2258, 2001.
DOI : 10.1212/WNL.57.12.2253

Y. Dauvilliers, I. Arnulf, and E. Mignot, Narcolepsy with cataplexy, The Lancet, vol.369, issue.9560, pp.499-511, 2007.
DOI : 10.1016/S0140-6736(07)60237-2
URL : https://hal.archives-ouvertes.fr/hal-00534816

Y. Dauvilliers, C. Baumann, B. Carlander, M. Bischof, and T. Blatter, CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions, Journal of Neurology, Neurosurgery & Psychiatry, vol.74, issue.12, pp.1667-1673, 2003.
DOI : 10.1136/jnnp.74.12.1667

T. Thannickal, R. Nienhuis, and J. Siegel, Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy, Sleep, vol.32, pp.993-998, 2009.

J. Hallmayer, J. Faraco, L. Lin, S. Hesselson, and J. Winkelmann, Narcolepsy is strongly associated with the T-cell receptor alpha locus, Nature Genetics, vol.29, issue.6, 2009.
DOI : 10.1093/hmg/ddn246

S. Overeem, B. Iii, J. Lammers, and G. , Narcolepsy: Immunological aspects, Sleep Medicine Reviews, vol.12, issue.2, pp.95-107, 2008.
DOI : 10.1016/j.smrv.2007.07.010
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2366136

V. Cvetkovic-lopes, L. Bayer, S. Dorsaz, S. Maret, and S. Pradervand, Elevated Tribbles homolog 2???specific antibody levels in narcolepsy patients, Journal of Clinical Investigation, vol.120, issue.3, pp.713-719, 2010.
DOI : 10.1172/JCI41366DS1

S. Tanaka, Y. Honda, Y. Inoue, and M. Honda, Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy, Sleep, vol.29, pp.633-638, 2006.

J. Black, M. Silber, L. Krahn, P. Fredrickson, and V. Pankratz, Analysis of hypocretin (orexin) antibodies in patients with narcolepsy, Sleep, vol.28, pp.427-431, 2005.

A. Smith, M. Jackson, P. Neufing, R. Mcevoy, and T. Gordon, A functional autoantibody in narcolepsy, The Lancet, vol.364, issue.9451, pp.2122-2124, 2004.
DOI : 10.1016/S0140-6736(04)17553-3

M. Jackson, J. Reed, A. Smith, and T. Gordon, An Autoantibody in Narcolepsy Disrupts Colonic Migrating Motor Complexes, Journal of Neuroscience, vol.28, issue.49, pp.13303-13309, 2008.
DOI : 10.1523/JNEUROSCI.4489-08.2008

Y. Dauvilliers, B. Abril, E. Mas, F. Michel, and M. Tafti, Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment, Neurology, vol.73, issue.16, pp.1333-1334, 2009.
DOI : 10.1212/WNL.0b013e3181bd1344

P. Grabar, Hypothesis. Auto-antibodies and immunological theories: An analytical review, Clinical Immunology and Immunopathology, vol.4, issue.4, pp.453-466, 1975.
DOI : 10.1016/0090-1229(75)90087-2

S. Avrameas, Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton', Immunol Today, vol.12, pp.154-159, 1991.

M. Carskadon, W. Dement, M. Mitler, T. Roth, and P. Westbrook, Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness, Sleep, vol.9, pp.519-524, 1986.

Y. Dauvilliers, J. Montplaisir, N. Molinari, B. Carlander, and B. Ondze, Age at onset of narcolepsy in two large populations of patients in France and Quebec, Neurology, vol.57, issue.11, pp.2029-2033, 2001.
DOI : 10.1212/WNL.57.11.2029

E. Mignot, G. Lammers, R. B. Okun, M. Nevsimalova, and S. , The Role of Cerebrospinal Fluid Hypocretin Measurement in the Diagnosis of Narcolepsy and Other Hypersomnias, Archives of Neurology, vol.59, issue.10, pp.1553-1562, 2002.
DOI : 10.1001/archneur.59.10.1553

S. Tafuri, L. Pavone, V. Mastellone, A. Spina, and L. Avallone, Expression of orexin A and its receptor 1 in the choroid plexuses from buffalo brain, Neuropeptides, vol.43, issue.2, pp.73-80, 2009.
DOI : 10.1016/j.npep.2009.01.003

H. Sinno, M. , D. Rego, J. Coëffier, M. Bole-feysot et al., Regulation of feeding and anxiety by ??-MSH reactive autoantibodies, Psychoneuroendocrinology, vol.34, issue.1, pp.140-149, 2009.
DOI : 10.1016/j.psyneuen.2008.08.021

S. Higuchi, A. Usui, M. Murasaki, S. Matsushita, and N. Nishioka, Plasma orexin-A is lower in patients with narcolepsy, Neuroscience Letters, vol.318, issue.2, pp.61-64, 2002.
DOI : 10.1016/S0304-3940(01)02476-4

S. Nishino and E. Mignot, Article reviewed: Plasma orexin-A is lower in patients with narcolepsy, Sleep Medicine, vol.3, issue.4, pp.377-378, 2002.
DOI : 10.1016/S1389-9457(02)00078-3

S. Tanaka and M. Honda, IgG Abnormality in Narcolepsy and Idiopathic Hypersomnia, PLoS ONE, vol.5, issue.3, p.9555
DOI : 10.1371/journal.pone.0009555.s001

F. Rossi, G. Dietrich, and M. Kazatchkine, Anti-idiotypes against Autoantibodies in Normal Immunoglobulins: Evidence for Network Regulation of Human Autoimmune Responses, Immunological Reviews, vol.134, issue.1, pp.135-149, 1989.
DOI : 10.1016/S0140-6736(85)91046-3

B. Roy, W. Bowen, J. Frazier, J. Rose, and H. Mcfarland, Human antiidiotypic antibody against opiate receptors, Annals of Neurology, vol.36, issue.1, pp.57-63, 1988.
DOI : 10.1002/ana.410240111

I. Dogan, B. Bertocci, V. Vilmont, F. Delbos, and J. Megret, Multiple layers of B cell memory with different effector functions, Nature Immunology, vol.181, issue.12, 2009.
DOI : 10.1084/jem.20050292

A. Macpherson and N. Harris, Opinion: Interactions between commensal intestinal bacteria and the immune system, Nature Reviews Immunology, vol.169, issue.6, pp.478-485, 2004.
DOI : 10.1038/nm0602-625

S. Fetissov, H. Sinno, M. Coëffier, M. Bole-feysot, C. Ducrotté et al., Autoantibodies against appetite-regulating peptide hormones and neuropeptides: Putative modulation by gut microflora, Nutrition, vol.24, issue.4, pp.348-359, 2008.
DOI : 10.1016/j.nut.2007.12.006

M. Oldstone, Molecular mimicry and immune-mediated diseases, Faseb J, vol.12, pp.1255-1265, 1998.

A. Aran, L. Lin, S. Nevsimalova, G. Plazzi, and S. Hong, Elevated antistreptococcal antibodies in patients with recent narcolepsy onset, Sleep, vol.32, pp.979-983, 2009.